Terlivaz 43825-0200
Generic: Terlipressin
Product NDC
43825-0200- Manufacturer
- Mallinckrodt Hospital Products Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 14, 2022
- Listing Expires
- December 31, 2026
- Application
- NDA022231
Need to source Terlivaz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terlipressin | .85 mg/5mL |
Drug Class
Vasopressin Receptor Agonist [EPC]Vasopressin Receptor Agonist [EPC]Vasopressin Receptor Agonists [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE